08:00 , Nov 11, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer B cell lymphoma 2 (BCL-2; BCL2); BCL-XL; myeloid leukemia cell differentiation protein (MCL-1); BCL2-related protein A1 (BCL2A1; BFL1) In vitro and mouse studies identified...